Table 1.
General preoperative information and intraoperative data categorized by the type of approach
| Index | Dual-approach (n = 33) | Single-approach (n = 93) | p-value |
|---|---|---|---|
| Sex ratio (male/female) | 25:8 (76:24) | 42:51 (45:55) | 0.002* |
| Age (yr) | 61.7 ± 11.32 | 58.56 ± 11.57 | 0.483 |
| BMI (kg/m2) | 20.57 ± 2.38 | 20.95 ± 2.35 | 0.96 |
| ASA classification | 0.382 | ||
| ASA 1 | 18 (54.5) | 60 (64.5) | |
| ASA 2 | 10 (30.3) | 26 (28.0) | |
| ASA 3 | 5 (15.2) | 7 (7.5) | |
| Median CA19-9 (U/mL) | 280.36 | 256.15 | 0.586 |
| Total bilirubin (μmol/L) | 112.15 ± 100.71 | 88.26 ± 81.39 | 0.282 |
| Directed bilirubin (μmol/L) | 79.50 ± 74.65 | 63.82 ± 61.95 | 0.602 |
| Medical history | 0.13 | ||
| Diabetes | 7 (21.2) | 11 (22.0) | |
| Hypertension | 2 (6.1) | 15 (30.0) | |
| Chronic pancreatitis | 6 (18.2) | 9 (18.0) | |
| Operative time (min) | 301.39 ± 59.65 | 289.86 ± 92.37 | 0.02* |
| Vascular resection/divestment | |||
| PV/SMV | 17 (51.5) | 3 (3.2) | < 0.001* |
| CHA/SMA resection/divestment | 8 (24.2) | 2 (2.2) | < 0.001* |
| Estimated blood loss (mL) | 219.23 ± 299.29 (60–1,500) | 124.85 ± 134.88 (30–800) | 0.049* |
Values are presented as mean ± standard deviation, number (%), or mean ± standard deviation (min–max).
BMI, body mass index; PV, portal vein; SMV, superior mesenteric vein; CHA, common hepatic artery; SMA, superior mesenteric artery.
Statistically significant (*p < 0.05).